Lassa Fever
📧 Sign up to get email alerts when something new happens for Lassa Fever.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Prevalence and Incidence of Lassa Virus Infection in Southern Mali
A completed clinical trial report updates on the prevalence and incidence of Lassa fever in Southern Mali.
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001) [Phase 1]
Phase 1 trial to evaluate the optimal dose of MV-LASV (V182-001) for Lassa fever has been completed.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of oral ARN-75039 in healthy adults has completed, in the context of dev…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions [Phase 1]
This Phase 1 pharmacokinetic study compared ARN-75039 tablets with excipients to neat ARN-75039 in hydroxypropyl methylcellulose capsules un…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever [Phase 2]
Phase 2 trial comparing pharmacokinetics, tolerability, and safety of favipiravir versus ribavirin for Lassa fever has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.